Characterization of HLA DR2 and DQ8 transgenic mouse with a new engineered mouse class II deletion, which lacks all

S Cheng1, M Smart, J Hanson

  • 1Department of Immunology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Journal of Autoimmunity
|November 6, 2003
PubMed